Alfuzosin Hydrochloride

Alfuzosin Hydrochloride is a uroselective alpha-1 adrenergic receptor blocker that relaxes smooth muscle in the prostate and bladder neck, providing symptomatic relief in benign prostatic hyperplasia. Simson Pharma's Alfuzosin Hydrochloride reference standard and impurities support assay and degradation-product testing for this urology-focused therapy.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Alfuzosin Hydrochloride Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.

Pharmaceutical Reference Standards / Impurity Standards

Alfuzosin Hydrochloride
Alfuzosin
Alfuzosin EP Impurity A
Alfuzosin EP Impurity A Hydrochloride
Alfuzosin EP Impurity B
Alfuzosin EP Impurity C
Alfuzosin EP Impurity D Monohydrochloride
Alfuzosin EP Impurity D Trihydrochloride
Alfuzosin EP Impurity E Hydrochloride
Alfuzosin EP Impurity G Dihydrochloride Dihydrate
Alfuzosin EP Impurity F Hydrochloride
2-Tetrahydrofuroic Acid
Alfuzosin Impurity 3
(2-Chloro-6,7-dimethoxyquinazoline-4-yl)-(3,4-dimethoxyphenyl)-amine
Alfuzosin EP Impurity F
6,7-Dimethoxy-N2-(3-(methylamino)propyl)quinazoline-2,4-diamine
N-Nitroso Alfuzosin

Metabolites

O-Demethylated Alfuzoisn Metabolite

Isotope Labelled Compounds

(±)-Alfuzosin D7 Hydrochloride
Alfuzosin-D7